Table 2.

Main clinical and demographical characteristics of the study subjects.

Patient	HIV status	CD4+ T-cell Status (cells/mm3)	Age (Yrs.)	Gender (M/F)	HCV type	CD4+ T-cell count (cells/mm3)		HCV-RNA (log10) IU/mL		Months between samplesb
						T0a	T1a	T0a	T1a
Group 1
1-1	Positive	<200	43	M	1a	153	133	6.15	5.64	15
1-2	Positive	<200	56	M	1a	165	177	5.35	5.61	17
1-3	Positive	<200	44	M	1a	111	N.D.d	5.66	5.79	15
1-4	Positive	>200	33	M	1a	663	585	5.85	5.26	14
1-5	Positive	>200	49	M	1a	489	731	5.79	5.57	11
1-6	Positive	>200	41	M	1a	722	1024	5.23	5.24	10
Group 2
2-1	Negative	N.A.c	54	M	1a	N.D.d	N.D.d	4.97	4.89	12
2-2	Negative	N.A.c	43	M	1a	N.D.d	N.D.d	5.14	4.82	14
2-3	Negative	N.A.c	37	M	1a	N.D.d	N.D.d	5.14	5.54	9

^aT0 = sample at baseline (time point 0); T1 = sample at follow-up (time point 1).

^bMean interval between samples was 13.9 ± 0.8 months (median 14 months, range 9–17).

^cNA = non applicable.

^dND = not done.